Personalized treatment approach

Doctors consider PSA levels, biopsy results, imaging, risk group, and patient priorities when choosing prostate cancer care.

“It's always good to get a different perspective and I welcome patients to do that”

William Coren's story

At 76, William Coren received high dose rate brachytherapy at Fox Chase Cancer Center in 2023. His PSA level dropped significantly and he continues coaching cross country and track.

Cancer characteristics matter

PSA levels indicate cancer risk, while biopsy results provide a Gleason score to determine cancer aggressiveness.

Patient health is key

Doctors assess age, overall health, lifestyle, and existing urinary, bowel, and sexual function before recommending treatment.

Treatment options differ

Some men with low risk prostate cancer may benefit from active surveillance instead of immediate treatment.

Specialist collaboration

Urologic oncologists and radiation specialists work together to create tailored treatment plans for complex cases.

Brachytherapy benefits

High dose rate brachytherapy places a radioactive source inside the prostate temporarily before removing it after treatment.

Treatment evolution

New radiation techniques allow more precise targeting while reducing exposure to healthy tissue.

Clinical trials

Researchers study new treatment combinations and genetic markers to improve prostate cancer care decisions.

Second opinions help

Patients benefit from second opinions to ensure treatment aligns with both cancer characteristics and personal needs.